Aniruddha Chatterjee
Overview
Explore the profile of Aniruddha Chatterjee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1600
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hossain S, Gimenez G, Stockwell P, Weeks R, Almomani S, Jones G, et al.
Cancer Lett
. 2025 Mar;
:217638.
PMID: 40089202
Successful immune checkpoint inhibitor (ICI) therapy occurs in only a fraction of melanoma patients, and yet all patients are susceptible to potentially serious ICI-related side-effects. No current biomarkers robustly predict...
2.
Yassi M, Moattar M, Parry M, Chatterjee A
Methods Mol Biol
. 2025 Feb;
2880:243-254.
PMID: 39900763
High-dimensional data expands the spatial dimension, leading to increased computational complexity and reduced generalization performance. Microarray data classification, such as diagnosing diseases like cancer, involves complex dimensions due to their...
3.
Mandpe S, Kole E, Parate V, Chatterjee A, Mujumdar A, Naik J
J Microencapsul
. 2024 Nov;
42(1):1-13.
PMID: 39548962
This study aims to develop and evaluate flurbiprofen-loaded polymeric nanoparticles to achieve sustained drug release, enhancing therapeutic efficacy and minimising dosing frequency for improved patient outcomes. Flurbiprofen-loaded polymeric nanoparticles were...
4.
Stockwell P, Rodger E, Gimenez G, Morison I, Chatterjee A
Curr Protoc
. 2024 Sep;
4(9):e70003.
PMID: 39258384
DNA methylation is well-established as a major epigenetic mechanism that can control gene expression and is involved in both normal development and disease. Analysis of high-throughput-sequencing-based DNA methylation data is...
5.
Gupta P, ONeill H, Wolvetang E, Chatterjee A, Gupta I
NAR Genom Bioinform
. 2024 May;
6(2):lqae047.
PMID: 38774511
With an increase in accuracy and throughput of long-read sequencing technologies, they are rapidly being assimilated into the single-cell sequencing pipelines. For transcriptome sequencing, these techniques provide RNA isoform-level information...
6.
Ezegbogu M, Wilkinson E, Reid G, Rodger E, Brockway B, Russell-Camp T, et al.
Trends Mol Med
. 2024 Apr;
30(5):499-515.
PMID: 38582623
The clinical use of cell-free DNA (cfDNA) methylation in managing lung cancer depends on its ability to differentiate between malignant and healthy cells, assign methylation changes to specific tissue sources,...
7.
Banerjee R, Ajithkumar P, Keestra N, Smith J, Gimenez G, Rodger E, et al.
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473261
Cutaneous melanoma is rapidly on the rise globally, surpassing the growth rate of other cancers, with metastasis being the primary cause of death in melanoma patients. Consequently, understanding the mechanisms...
8.
Srinath S, Jishnu P, Varghese V, Shukla V, Adiga D, Mallya S, et al.
Mol Oncol
. 2024 Feb;
18(6):1608-1630.
PMID: 38400534
Cervical cancer (CC) is a key contributor to cancer-related mortality in several countries. The identification of molecular markers and the underlying mechanism may help improve CC management. We studied the...
9.
Zhang X, Barnett E, Smith J, Wilkinson E, Subramaniam R, Zarrabi A, et al.
Int Rev Cell Mol Biol
. 2024 Feb;
383:41-66.
PMID: 38359970
Prostate cancer is the second most prevalent cancer in men globally. De novo neuroendocrine prostate cancer (NEPC) is uncommon at initial diagnosis, however, (treatment-induced) t-NEPC emerges in up to 25%...
10.
Wei H, Zhang Y, Jia Y, Chen X, Niu T, Chatterjee A, et al.
MedComm (2020)
. 2024 Jan;
5(2):e470.
PMID: 38283176
Heat shock protein 90 (Hsp90) is a predominant member among Heat shock proteins (HSPs), playing a central role in cellular protection and maintenance by aiding in the folding, stabilization, and...